Ausgabe 12/2013
Inhalt (7 Artikel)
Adis Drug Clinical Q&A
Inhaled glycopyrronium bromide: a guide to its use in moderate to severe chronic obstructive pulmonary disease
Katherine A. Lyseng-Williamson, Natalie J. Carter
Adis Drug Clinical Q&A
Lomitapide: a guide to its use in adults with homozygous familial hypercholesterolaemia in the EU
Katherine A. Lyseng-Willliamson, Caroline M. Perry
Adis Pharmacoeconomic Drug Q&A
Ticagrelor: a review of its cost effectiveness in the management of acute coronary syndromes
Katherine A. Lyseng-Williamson
Practical Issues and Updates
Distinguishing ‘adverse drug effects’ from ‘adverse drug reactions’: proposed definitions
Case Report
When is the best time for patients with irregular schedules to take agomelatine?
Martina Hahn, Maren Lehmann, Sibylle C. Roll, Renate Grohman